Should I Buy SCYX? SCYX 2026 Analysis

Should You Buy SCYNEXIS Inc (SCYX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

0.740

1 Day change

-4.39%

52 Week Range

1.310

Analysis Updated At

2026/01/26

SCYNEXIS Inc (SCYX) does not present a strong buy opportunity for a beginner investor with a long-term horizon at this time. While there are positive catalysts such as FDA designations and promising drug developments, the company's financial performance is weak, and technical indicators suggest the stock is overbought. Additionally, there are no strong trading signals or significant insider or hedge fund activity to support a buy decision.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 90.513, signaling an overbought condition. The stock is trading near resistance levels (R1: 0.797, R2: 0.846), which could limit further upside in the short term. Moving averages are converging, suggesting indecision in the market.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

SCY-247 received FDA QIDP and Fast Track designations, ensuring market exclusivity for at least 10 years post-approval. The drug has shown potent antifungal activity against multi-drug-resistant Candida auris, addressing an urgent market need. Phase 1 and Phase 2 studies are planned for 2026.

Neutral/Negative Catalysts

Despite an improvement in net income and EPS, the company remains unprofitable. No recent insider or hedge fund activity indicates a lack of strong institutional confidence.

Financial Performance

In Q3 2025, revenue dropped to $334,000 (-49.39% YoY). However, net income improved to -$8,591,000 (+205.95% YoY), and EPS increased to -0.17 (+183.33% YoY). Gross margin remained stable at 100%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes were provided for SCYX.

2 Analyst Rating

Wall Street analysts forecast SCYX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SCYX is 3.5 USD with a low forecast of 3 USD and a high forecast of 4 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.775

Low

Averages

3.5

High